Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone acetate in metastatic castration-resistant prostate cancer
RBR-9ns5dbPhase 2Completed
- Sponsor
- Centro Universitário Faculdade de Medicina do ABC
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abiraterone and prednisone in prostate cancer (PCa), sponsored by Centro Universitário Faculdade de Medicina do ABC. Started Oct 2014; status: completed.
02
Drugs
abirateroneprednisone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on RBR-9ns5db.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9ns5db.